Sree Rayalaseema Hi-Strength Hypo Limited (IN:SRHHYPOLTD)
:SRHHYPOLTD
Want to see IN:SRHHYPOLTD full AI Analyst Report?
Top Page
Sree Rayalaseema Hi-Strength Hypo Limited
(SRHHYPOLTD)
Select Model
Select Model
Rating:63Neutral
Price Target:
₹491.00
▼(-5.24% Downside)
Action:Reiterated
Date:11/15/25
The stock score is primarily influenced by strong financial performance, characterized by profitability and low leverage. However, technical analysis indicates bearish momentum, which is a significant risk factor. Valuation is reasonable, but the low dividend yield limits income potential. The absence of earnings call data and notable corporate events means these factors do not influence the score.
Positive Factors
Conservative balance sheet / low leverage
A low debt-to-equity posture provides durable financial flexibility for a capital-intensive chemical business. It reduces refinancing and solvency risk, supports investment in capacity or maintenance, and helps absorb cyclical downturns without forcing distress sales or cutbacks.
Negative Factors
Inconsistent revenue growth; recent decline
Uneven top-line growth undermines long-term scalability and makes fixed-cost absorption harder in a capital-heavy industry. A declining revenue trend can pressure margins, limit ability to expand capacity, and reduce predictability of returns over a 2–6 month horizon and beyond.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet / low leverage
A low debt-to-equity posture provides durable financial flexibility for a capital-intensive chemical business. It reduces refinancing and solvency risk, supports investment in capacity or maintenance, and helps absorb cyclical downturns without forcing distress sales or cutbacks.
Read all positive factors
Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) vs. iShares MSCI India ETF (INDA)
Market Cap
₹8.81B
Dividend Yield0.56%
Average Volume (3M)1.02K
Price to Earnings (P/E)9.3
Beta (1Y)1.40
Revenue Growth3.39%
EPS Growth7.56%
CountryIN
Employees498
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)52.00
Shares Outstanding17,164,820
10 Day Avg. Volume725
30 Day Avg. Volume1,017
Financial Highlights & Ratios
PEG Ratio0.71
Price to Book (P/B)0.95
Price to Sales (P/S)1.36
P/FCF Ratio9.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sree Rayalaseema Hi-Strength Hypo Limited Business Overview & Revenue Model
Company Description
Sree Rayalaseema Hi-Strength Hypo Limited engages in the production and sale of chemicals in India. The company operates through two segments, Chemical Manufacturing and Power generation. It provides sulphuric, chlorosulphonic, hydrochloric, and m...
How the Company Makes Money
SRHHYPOLTD makes money by manufacturing and selling industrial chemicals, with revenue largely driven by (1) sales of calcium hypochlorite and other hypochlorite/chlorination products used for disinfection and water treatment, and (2) sales of chl...
Sree Rayalaseema Hi-Strength Hypo Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.62B | 6.38B | 8.62B | 16.50B | 12.63B | 9.09B |
| Gross Profit | 2.97B | 2.39B | 2.51B | 3.44B | 3.36B | 2.77B |
| EBITDA | 1.30B | 1.28B | 1.19B | 2.15B | 1.59B | 1.36B |
| Net Income | 892.58M | 874.69M | 789.70M | 1.54B | 1.03B | 605.71M |
Balance Sheet | ||||||
| Total Assets | 11.66B | 10.71B | 9.14B | 9.23B | 7.88B | 5.19B |
| Cash, Cash Equivalents and Short-Term Investments | 4.13B | 3.74B | 3.29B | 2.42B | 1.13B | 98.35M |
| Total Debt | 141.74M | 157.43M | 129.21M | 191.71M | 283.63M | 715.11M |
| Total Liabilities | 1.47B | 1.36B | 1.13B | 1.72B | 2.17B | 1.31B |
| Stockholders Equity | 10.05B | 9.20B | 8.01B | 7.51B | 5.70B | 3.88B |
Cash Flow | ||||||
| Free Cash Flow | 123.31M | 892.96M | 1.20B | 1.33B | 453.45M | 501.22M |
| Operating Cash Flow | 188.00M | 654.83M | 1.40B | 1.41B | 597.50M | 705.64M |
| Investing Cash Flow | 245.05M | -82.31M | -199.94M | -1.12B | -11.69M | -1.15B |
| Financing Cash Flow | -35.12M | -172.98M | -168.25M | -166.51M | -513.24M | 101.58M |
Sree Rayalaseema Hi-Strength Hypo Limited Technical Analysis
Positive
518.15
Price Trends
467.26
Positive
475.65
Positive
522.32
Negative
Market Momentum
10.37
Positive
57.08
Neutral
23.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SRHHYPOLTD, the sentiment is Positive. The current price of 518.15 is above the 20-day moving average (MA) of 506.94, above the 50-day MA of 467.26, and below the 200-day MA of 522.32, indicating a neutral trend. The MACD of 10.37 indicates Positive momentum. The RSI at 57.08 is Neutral, neither overbought nor oversold. The STOCH value of 23.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SRHHYPOLTD.
Sree Rayalaseema Hi-Strength Hypo Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ₹76.48B | 6.67 | ― | 3.68% | -1.51% | 35.32% | |
75 Outperform | ₹41.95B | 8.43 | ― | 2.10% | -3.75% | -23.83% | |
65 Neutral | ₹52.67B | -46.40 | ― | 3.11% | 7.73% | 92.87% | |
63 Neutral | ₹8.81B | 9.34 | ― | 0.56% | 3.39% | 7.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | ₹13.79B | 23.02 | ― | 0.16% | 7.16% | 58.82% | |
54 Neutral | ₹3.93B | 23.33 | ― | ― | 47.19% | 657.86% |
* Basic Materials Sector Average
IN:SRHHYPOLTD
Sree Rayalaseema Hi-Strength Hypo Limited
532.25
-42.45
-7.39%
IN:DCW
DCW Ltd.
46.74
-29.24
-38.48%
IN:GHCL
Ghcl Limited
453.30
-156.63
-25.68%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
522.05
29.56
6.00%
IN:GUJALKALI
Gujarat Alkalies & Chemicals Ltd.
713.50
131.00
22.49%
IN:LORDSCHLO
Lords Chloro Alkali Limited
135.70
-12.25
-8.28%
Sree Rayalaseema Hi-Strength Hypo Limited Corporate Events
Sree Rayalaseema Hi-Strength Hypo files nil report on physical share transfer window
Mar 18, 2026
Sree Rayalaseema Hi-Strength Hypo Limited has informed the stock exchanges that it has submitted its report on the special window for lodgement and re-lodgement of transfer requests for physical shares, as mandated by a recent SEBI circular. The r...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.